Diazepam
- Product NDC
- 62332-811
- Requested package NDC
- 62332-811-20
- 11-digit product format
- 623320811
- Labeler code
- 62332
- Product ID
- 62332-811_3779694b-e1cc-44ec-92c3-3299d3734bee
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Diazepam
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR; INTRAVENOUS
- Labeler
- Alembic Pharmaceuticals Inc.
- Application
- ANDA218450
- Marketing category
- ANDA
- Marketing start
- 2024-04-25
- Substance
- DIAZEPAM
- Active strength
- 10 mg/2mL
- Pharmacologic classes
- Benzodiazepine [EPC], Benzodiazepines [CS]
- DEA schedule
- CIV
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A218450-001 | DIAZEPAM | DIAZEPAM | 10MG/2ML (5MG/ML) | INJECTABLE / INJECTION | AP | 2024-04-25 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A218450-001 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A218450-001 | DIAZEPAM | 10MG/2ML (5MG/ML) | INJECTABLE / INJECTION | AP | 2024-04-25 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A218450-001 | DIAZEPAM | 10MG/2ML (5MG/ML) | INJECTABLE / INJECTION | AP | 2024-04-25 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A218450-001 | DIAZEPAM | 10MG/2ML (5MG/ML) | INJECTABLE / INJECTION | AP | 2024-04-25 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A218450-001 | DIAZEPAM | 10MG/2ML (5MG/ML) | INJECTABLE / INJECTION | AP | 2024-04-25 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A218450-001 | DIAZEPAM | 10MG/2ML (5MG/ML) | INJECTABLE / INJECTION | AP | 2024-04-25 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A218450-001 | DIAZEPAM | 10MG/2ML (5MG/ML) | INJECTABLE / INJECTION | AP | 2024-04-25 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A218450-001 | DIAZEPAM | 10MG/2ML (5MG/ML) | INJECTABLE / INJECTION | AP | 2024-04-25 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A218450-001 | DIAZEPAM | 10MG/2ML (5MG/ML) | INJECTABLE / INJECTION | AP | 2024-04-25 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A218450-001 | DIAZEPAM | 10MG/2ML (5MG/ML) | INJECTABLE / INJECTION | AP | 2024-04-25 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A218450-001 | DIAZEPAM | 10MG/2ML (5MG/ML) | INJECTABLE / INJECTION | AP | 2024-04-25 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A218450-001 | DIAZEPAM | 10MG/2ML (5MG/ML) | INJECTABLE / INJECTION | AP | 2024-04-25 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A218450-001 | DIAZEPAM | 10MG/2ML (5MG/ML) | INJECTABLE / INJECTION | AP | 2024-04-25 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A218450-001 | DIAZEPAM | 10MG/2ML (5MG/ML) | INJECTABLE / INJECTION | AP | 2024-04-25 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A218450-001 | DIAZEPAM | 10MG/2ML (5MG/ML) | INJECTABLE / INJECTION | AP | 2024-04-25 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A218450-001 | DIAZEPAM | 10MG/2ML (5MG/ML) | INJECTABLE / INJECTION | AP | 2024-04-25 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A218450-001 | DIAZEPAM | 10MG/2ML (5MG/ML) | INJECTABLE / INJECTION | AP | 2024-04-25 | 8072bd15b7f6… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218450-001 | DIAZEPAM | 10MG/2ML (5MG/ML) | INJECTABLE / INJECTION | AP | 2024-04-25 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A218450-001 | AP | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A218450-001 | AP | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A218450-001 | AP | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A218450-001 | AP | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A218450-001 | AP | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A218450-001 | AP | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A218450-001 | AP | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A218450-001 | AP | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A218450-001 | AP | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A218450-001 | AP | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A218450-001 | AP | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A218450-001 | AP | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A218450-001 | AP | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A218450-001 | AP | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A218450-001 | AP | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A218450-001 | AP | 1 | 8072bd15b7f6… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218450-001 | AP | 1 | a50c72e98297… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Diazepam
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| DIAZEPAM | 10 mg/2mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| Q3JTX2Q7TU | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 2120550 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 6b6ca65b-4ede-47b9-bbf3-05bb67c0c71d | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 69057c52-36b0-21c0-02d6-d697be15c03c | Product name | 4 | 20260305 |
| da74e203-d183-4c62-8511-c3ef56b5964e | Product name | 1 | 20250213 |
| 2792dd44-ff30-4712-8b05-1850c2b4d307 | Product name | 3 | 20250211 |
| 2fd3ebb9-86c1-64e3-e9b6-3c2ba01c6876 | Product name | 2 | 20250102 |
| 0f898f8b-23f1-b816-6bfe-c7f8aac7e42b | Product name | 2 | 20240529 |
| c6f86816-7da6-43ea-8c25-ac9758311cc5 | Product name | 1 | 20220118 |
| 2c487d7e-cbfc-4699-9c83-5c1c7521cde9 | Product name | 1 | 20200610 |
| 252e11b6-1a9a-4283-a242-df2c129c496d | Product name | 3 | 20170717 |
| 02ac201d-7ee6-00c9-f963-81bb5a506b68 | Product name | 3 | 20160816 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 62332-811-02 | Diazepam | 2 mL in 1 SYRINGE, GLASS | INJECTION, SOLUTION | 2 | 4 | |
| 62332-811-20 | Diazepam | 10 in 1 CARTON | INJECTION, SOLUTION | 10 | 4 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 62332-811-02 | ML - Milliliter | 62332-811 | a3ecc29f-9e07-4ba5-acd3-4caf48d9f9f8 | 1 | 2024-08-12 |
| 62332-811-20 | ML - Milliliter | 62332-811 | 2268a716-724a-42b1-b090-6c6c56dc1074 | 1 | 2024-08-12 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Diazepam | DIAZEPAM | REMEDYREPACK INC. | b4a045e4-d6ce-475d-abe4-590941bd3815 | 2026-07-21 | Boxed warning, Warnings, Adverse reactions | 218450 ANDA218450 |
| Diazepam | DIAZEPAM | Sagent Pharmaceuticals | 7a912f1a-deee-46df-a8df-22a0afb06529 | 2026-02-04 | Boxed warning, Warnings, Adverse reactions | 218450 ANDA218450 |
| Diazepam | DIAZEPAM | Alembic Pharmaceuticals Inc. | 6b6ca65b-4ede-47b9-bbf3-05bb67c0c71d | 2024-04-29 | Boxed warning, Warnings, Adverse reactions | 218450 ANDA218450 62332-811-20 62332-811 62332081120 |
| Diazepam | DIAZEPAM | Alembic Pharmaceuticals Limited | 1632f040-3b2c-43da-a42f-f2baf5ec778a | 2024-04-29 | Boxed warning, Warnings, Adverse reactions | 218450 ANDA218450 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 2120550 | diazePAM 10 MG in 2 ML Prefilled Syringe | PSN | 6b6ca65b-4ede-47b9-bbf3-05bb67c0c71d | 4 |
| 2120550 | 2 ML diazepam 5 MG/ML Prefilled Syringe | SCD | 6b6ca65b-4ede-47b9-bbf3-05bb67c0c71d | 4 |
| 2120550 | diazepam 10 MG per 2 ML Prefilled Syringe | SY | 6b6ca65b-4ede-47b9-bbf3-05bb67c0c71d | 4 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|
| 62332-811-20 | 62332081120 | 10 SYRINGE, GLASS in 1 CARTON (62332-811-20) / 2 mL in 1 SYRINGE, GLASS (62332-811-02) | 2024-04-25 | No | No | Current |